Found: 18
Select item for more details and to access through your institution.
Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 1, p. 161, doi. 10.1210/clinem/dgad438
- By:
- Publication type:
- Article
Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 16, p. 8851, doi. 10.3390/ijms23168851
- By:
- Publication type:
- Article
Decreased basal hepatic glucose uptake in impaired fasting glucose.
- Published in:
- Diabetologia, 2017, v. 60, n. 7, p. 1325, doi. 10.1007/s00125-017-4252-0
- By:
- Publication type:
- Article
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT).
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 899, doi. 10.1111/dom.14650
- By:
- Publication type:
- Article
Plasma insulin is required for the increase in plasma angiopoietin‐like protein 8 in response to nutrient ingestion.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 6, p. 1, doi. 10.1002/dmrr.3643
- By:
- Publication type:
- Article
Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2019, v. 104, n. 1, p. 163, doi. 10.1210/jc.2017-01866
- By:
- Publication type:
- Article
Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose.
- Published in:
- Diabetes Care, 2022, v. 45, n. 6, p. 1372, doi. 10.2337/dc21-1798
- By:
- Publication type:
- Article
Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion.
- Published in:
- 2020
- By:
- Publication type:
- journal article
756-P: Bromocriptine-QR (BQR) Ameliorates Immunocyte Pro-Oxidative Stress/Proinflammatory (POS/PI) and ER Stress Phenotype in T2DM Subjects.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-756-P
- By:
- Publication type:
- Article
184-OR: Liver Fibrosis Scores Do Not Predict Response to Therapy in T2DM.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-184-OR
- By:
- Publication type:
- Article
352-OR: Combination Therapy with Dapagliflozin plus Exenatide on Endogenous Glucose Production: A Mechanism of Action Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-352-OR
- By:
- Publication type:
- Article
1136-P: Glucose Kinetics during Oral Glucose Challenge following Administration of Exenatide and Dapagliflozin Alone and in Combination in Type 2 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1136-P
- By:
- Publication type:
- Article
1070-P: Bromocriptine-QR (BQR) Ameliorates a Pro-oxidative Stress/Proinflammatory (POS/PI) Monocyte Phenotype in Poorly Controlled T2DM Subjects.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1070-P
- By:
- Publication type:
- Article
Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
155-LB: The Increase in Endogenous Glucose Production with SGLT2 Inhibition Is Unchanged by Renal Denervation but Highly Correlates to Urinary Glucose Excretion.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-155-LB
- By:
- Publication type:
- Article
1166-P: Bromocriptine-QR (BQR) Therapy Reduces Elevated Sympathetic Nervous System Activity (SNSA) and Oxidative Stress (OS) in Type 2 Diabetes (T2D) Subjects whose Dysglycemia Is Poorly Controlled on GLP-1 Receptor Agonist (GLP-1RA).
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1166-P
- By:
- Publication type:
- Article
246-OR: Contribution of Plasma Glucose and Hormones to the Acute Compensatory Rise in Endogenous Glucose Production (EGP) during Glucosuria in T2D Patients.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-246-OR
- By:
- Publication type:
- Article